Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study.

Authors :: Papini M
Cusano F
Romanelli M
Burlando M
Stinco G
Girolomoni G
Peris K
Potenza C
Offidani A
Bartezaghi M
Aloisi E
Costanzo A
Source :: The British journal of dermatology [Br J Dermatol] 2019 Aug; Vol. 181 (2), pp. 413-414. Date of Electronic Publication: 2019 May 29.
Publication Year :: 2019

Subjects :: Adult
Antibodies, Monoclonal, Humanized adverse effects
Drug Administration Schedule
Female
HLA-C Antigens immunology
Humans
Injections, Subcutaneous
Male
Middle Aged
Prospective Studies
Psoriasis blood
Psoriasis diagnosis
Psoriasis immunology
Severity of Illness Index
Treatment Outcome
Antibodies, Monoclonal, Humanized administration & dosage
HLA-C Antigens blood
Psoriasis drug therapy

Full Text Access

Tools